MENA: Antisera Market 2024

Antisera Market Size in MENA

In 2021, the MENA's antisera market decreased by -33.7% to $X for the first time since 2016, thus ending a four-year rising trend. The total consumption indicated notable growth from 2012 to 2021: its value increased at an average annual rate of +3.4% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The level of consumption peaked at $X in 2020, and then declined remarkably in the following year.

Antisera Production in MENA

In value terms, antisera production skyrocketed to $X in 2021 estimated in export price. Overall, production showed a sharp decrease. The pace of growth was the most pronounced in 2019 when the production volume increased by 334% against the previous year. Over the period under review, production reached the maximum level at $X in 2017; however, from 2018 to 2021, production remained at a lower figure.

Antisera Exports

Exports in MENA

In 2021, antisera exports in MENA soared to X tons, with an increase of 62% on the previous year. Over the period under review, exports continue to indicate a significant increase. The pace of growth was the most pronounced in 2014 when exports increased by 124% against the previous year. The volume of export peaked in 2021 and is likely to continue growth in the immediate term.

In value terms, antisera exports rose notably to $X in 2021. In general, exports enjoyed significant growth. The growth pace was the most rapid in 2014 with an increase of 75%. Over the period under review, the exports hit record highs in 2021 and are likely to see gradual growth in the near future.

Exports by Country

Turkey prevails in exports structure, reaching X tons, which was approx. 89% of total exports in 2021. It was distantly followed by Iran (X tons), committing a 4.6% share of total exports. Israel (X tons) held a relatively small share of total exports.

Turkey was also the fastest-growing in terms of the antisera and other blood fractions exports, with a CAGR of +43.1% from 2012 to 2021. At the same time, Iran (+8.6%) displayed positive paces of growth. By contrast, Israel (-9.0%) illustrated a downward trend over the same period. From 2012 to 2021, the share of Turkey increased by +63 percentage points.

In value terms, Turkey ($X) remains the largest antisera supplier in MENA, comprising 74% of total exports. The second position in the ranking was taken by Israel ($X), with a 15% share of total exports.

In Turkey, antisera exports increased at an average annual rate of +71.9% over the period from 2012-2021. The remaining exporting countries recorded the following average annual rates of exports growth: Israel (+4.5% per year) and Iran (+4.2% per year).

Export Prices by Country

In 2021, the export price in MENA amounted to $X per ton, dropping by -30.2% against the previous year. Overall, the export price saw a slight decrease. The pace of growth was the most pronounced in 2020 an increase of 26% against the previous year. As a result, the export price attained the peak level of $X per ton, and then contracted remarkably in the following year.

Prices varied noticeably country of origin: the country with the highest price was Israel ($X per ton), while Turkey ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Turkey (+20.1%), while the other leaders experienced mixed trends in the export price figures.

Antisera Imports

Imports in MENA

In 2021, approx. X tons of antisera and other blood fractions were imported in MENA; increasing by 3% on 2020. In general, imports enjoyed a strong increase. The pace of growth was the most pronounced in 2014 when imports increased by 25%. Over the period under review, imports reached the peak figure in 2021 and are expected to retain growth in the immediate term.

In value terms, antisera imports surged to $X in 2021. Overall, imports recorded a strong expansion. The pace of growth appeared the most rapid in 2014 when imports increased by 27%. The level of import peaked in 2021 and is expected to retain growth in the immediate term.

Imports by Country

In 2021, Turkey (X tons), distantly followed by Israel (X tons), Saudi Arabia (X tons), Algeria (X tons), Egypt (X tons) and Iraq (X tons) represented the largest importers of antisera and other blood fractions, together achieving 72% of total imports. Lebanon (X tons), Iran (X tons), the United Arab Emirates (X tons), Libya (X tons), Jordan (X tons), Oman (X tons) and Kuwait (X tons) held a relatively small share of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the leading importing countries, was attained by Saudi Arabia (with a CAGR of +30.3%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Turkey ($X) constitutes the largest market for imported antisera and other blood fractions in MENA, comprising 33% of total imports. The second position in the ranking was held by Israel ($X), with a 14% share of total imports. It was followed by Saudi Arabia, with a 10% share.

In Turkey, antisera imports expanded at an average annual rate of +14.8% over the period from 2012-2021. The remaining importing countries recorded the following average annual rates of imports growth: Israel (+26.0% per year) and Saudi Arabia (+36.5% per year).

Import Prices by Country

In 2021, the import price in MENA amounted to $X per ton, increasing by 16% against the previous year. Over the last nine years, it increased at an average annual rate of +3.5%. As a result, import price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was Kuwait ($X per ton), while Jordan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Kuwait (+12.3%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform